INLEXZO

What this means for you

Not registered yet, but its 02 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98531370

Mark type

Stylized text

Filed

02 May 2024

Published for opposition

14 Jan 2025

Attorney of record

Danielle Rivera

Goods and services

• Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers
• Class 010 — Medical apparatus: Medical apparatus for introducing pharmaceutical preparations into the human body; implantable medical device for introducing pharmaceutical preparations into the human body

Owner

• Johnson & Johnson, New Brunswick, NJ, US
• Johnson & Johnson, New Brunswick, NJ, US

Prosecution history

• 20 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
• 21 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 19 Aug 2025 — SOU EXTENSION 1 GRANTED
• 19 Aug 2025 — SOU EXTENSION 1 FILED
• 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
• 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 14 Jan 2025 — PUBLISHED FOR OPPOSITION
• 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 20 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 19 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 19 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 19 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 19 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 19 Nov 2024 — NON-FINAL ACTION E-MAILED